Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001179110-20-004335

Chief Scientific Officer acquired 31,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Chen Hongming · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-03-30 Exercise or conversion : show line 1 in the form +31,000 $2.30 $71,300 86,849 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-30 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −31,000 $2.30 2024-10-01 31,000 75,236 D
Loading xslF345X03/edgar.xml…